DE69223603D1 - Optisch aktives zwischenprodukt und dessen herstellung - Google Patents

Optisch aktives zwischenprodukt und dessen herstellung

Info

Publication number
DE69223603D1
DE69223603D1 DE69223603T DE69223603T DE69223603D1 DE 69223603 D1 DE69223603 D1 DE 69223603D1 DE 69223603 T DE69223603 T DE 69223603T DE 69223603 T DE69223603 T DE 69223603T DE 69223603 D1 DE69223603 D1 DE 69223603D1
Authority
DE
Germany
Prior art keywords
optically active
production
intermediate product
active intermediate
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69223603T
Other languages
English (en)
Other versions
DE69223603T2 (de
Inventor
Toshiro Konoike
Yoshitaka Araki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE69223603D1 publication Critical patent/DE69223603D1/de
Publication of DE69223603T2 publication Critical patent/DE69223603T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5352Phosphoranes containing the structure P=C-
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
DE69223603T 1991-06-19 1992-05-14 Optisch aktives zwischenprodukt und dessen herstellung Expired - Lifetime DE69223603T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17620991 1991-06-19
PCT/JP1992/000611 WO1992022560A1 (en) 1991-06-19 1992-05-14 Optically active intermediate and production thereof

Publications (2)

Publication Number Publication Date
DE69223603D1 true DE69223603D1 (de) 1998-01-29
DE69223603T2 DE69223603T2 (de) 1998-04-09

Family

ID=16009533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69223603T Expired - Lifetime DE69223603T2 (de) 1991-06-19 1992-05-14 Optisch aktives zwischenprodukt und dessen herstellung

Country Status (11)

Country Link
US (1) US5354879A (de)
EP (1) EP0554455B1 (de)
JP (2) JP3233403B2 (de)
KR (1) KR100216011B1 (de)
AT (1) ATE161262T1 (de)
DE (1) DE69223603T2 (de)
DK (1) DK0554455T3 (de)
ES (1) ES2110499T3 (de)
GR (1) GR3026204T3 (de)
TW (1) TW201730B (de)
WO (1) WO1992022560A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717124A (en) * 1993-03-30 1998-02-10 Ube Industries, Ltd. Process for preparation of oxyglutaric acid ester derivatives
DE69424463T2 (de) * 1993-03-30 2000-09-14 Ube Industries Verfahren zur Herstellung von Ester-Derivaten der Oxyglutar-Säure
US6376476B1 (en) * 1996-12-13 2002-04-23 Zymogenetics Corporation Isoprenoid pathway inhibitors for stimulating bone growth
US6121475A (en) * 1999-09-17 2000-09-19 Ube Industries, Ltd. Preparation of optically active β-hydroxyester derivatives and platinum-containing catalyst
KR100511533B1 (ko) * 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
GB0211751D0 (en) * 2002-05-22 2002-07-03 Avecia Ltd Compound and process
US7396927B2 (en) * 2003-08-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
TW200526596A (en) 2003-11-24 2005-08-16 Teva Pharma Crystalline ammonium salts of rosuvastatin
EP1689723B1 (de) * 2003-12-02 2011-04-27 Teva Pharmaceutical Industries, Ltd. Referenzstandard zur charakterisierung von rosuvastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US7179916B2 (en) * 2004-07-13 2007-02-20 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
KR100945763B1 (ko) * 2005-02-22 2010-03-08 테바 파마슈티컬 인더스트리즈 리미티드 로수바스타틴의 제조 방법
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
KR20070062996A (ko) 2005-08-16 2007-06-18 테바 파마슈티컬 인더스트리즈 리미티드 결정성 로수바스타틴 중간체
CN1958593B (zh) * 2005-11-03 2010-05-05 上海医药工业研究院 一种用于合成瑞舒伐他汀钙的中间体的制备方法
PL2172471T3 (pl) * 2007-04-18 2013-08-30 Teva Pharma Sposób otrzymywania produktów pośrednich inhibitorów reduktazy HMG-CoA
WO2009009152A1 (en) 2007-07-12 2009-01-15 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation
CA2696381A1 (en) 2007-08-28 2009-03-05 Ratiopharm Gmbh Process for preparing pentanoic diacid derivatives
CN101735272B (zh) * 2009-12-11 2012-10-31 重庆博腾制药科技股份有限公司 瑞舒伐他汀钙中间体的制备方法
CA2857078A1 (en) * 2011-11-28 2013-06-06 Mylan Laboratories Ltd Process for producing chiral statin side chain intermediates employing candida/antarctica lipase b

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421555A (en) * 1972-03-17 1976-01-21 Searle & Co Process for the stereoselective production of intermediates in the synthesis of pge1 and derivatives
US3907852A (en) * 1972-06-23 1975-09-23 Exxon Research Engineering Co Silylhydrocarbyl phosphines and related compounds
DE3722807A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
WO1989003212A1 (en) * 1987-10-13 1989-04-20 Pfizer Inc. 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
US4804770A (en) * 1988-04-29 1989-02-14 E. R. Squibb & Sons, Inc. Process for preparing a keto-phosphonate intermediate useful in preparing HMG-CoA reductase inhibitors
DE3832570A1 (de) * 1988-09-24 1990-03-29 Hoechst Ag 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
JP2719723B2 (ja) * 1988-12-14 1998-02-25 塩野義製薬株式会社 アリール酢酸モノエステル類およびその製造法
US5117039A (en) * 1988-12-14 1992-05-26 Shionogi & Co., Ltd. Monoesters of arylacetic acid and the process thereof
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives

Also Published As

Publication number Publication date
DK0554455T3 (da) 1998-01-19
DE69223603T2 (de) 1998-04-09
ATE161262T1 (de) 1998-01-15
KR100216011B1 (ko) 1999-08-16
KR930701460A (ko) 1993-06-11
JP2002088054A (ja) 2002-03-27
JP3635247B2 (ja) 2005-04-06
EP0554455B1 (de) 1997-12-17
EP0554455A1 (de) 1993-08-11
EP0554455A4 (de) 1994-03-23
US5354879A (en) 1994-10-11
TW201730B (de) 1993-03-11
JP3233403B2 (ja) 2001-11-26
WO1992022560A1 (en) 1992-12-23
GR3026204T3 (en) 1998-05-29
ES2110499T3 (es) 1998-02-16

Similar Documents

Publication Publication Date Title
DE69223603D1 (de) Optisch aktives zwischenprodukt und dessen herstellung
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
NO991019L (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
ES2119190T3 (es) Procedimiento para producir un compuesto de lignano.
ES2157214T3 (es) Procedimiento para producir derivados de azetidinona sustituidos en posicion 4.
DE69333788D1 (de) Zwischenprodukt zur Herstellung von D-chiro-inosose und (+)-D-chiro-inositol
AU689459B2 (en) Process for the preparation of aminotriazine derivatives
AU644919B2 (en) Process for the production of (S)-vinyl and allenyl gaba
ES2033313T3 (es) Procedimiento de sintesis de azetidinonas.
FI942167A (fi) Optisesti aktiivinen 1-fenyylipyrrolidonijohdannainen, välituote sen valmistamiseksi ja menetelmä molempien valmistamiseksi
EP0441116A3 (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
JPS6490161A (en) Production of optically active cyanohydrin or its enantiomer
EP1104424A4 (de) Verfahren zur synthese von carbapenem-zwischenprodukten und hergestellte verbindungen
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 554455

Country of ref document: EP